/ Chinese Healthcare
/ Company News
/ Events
/ Generic
/ Industry Updates
/ Innovation
/ Investor Relations

Category: Industry Updates

TPP Healthcare to Offer 1:1 Meeting Space during JP Morgan and Biotech Showcase Healthcare Week in San Francisco – January 8-10, 2018

Chinese Healthcare, Company News, Events, Industry Updates, Investor Relations

TPP Healthcare, a strategic advisory firm specializing in cross-border transactions between US, Europe and China’s healthcare companies, in partnership with B. Riley FBR, Inc. and Citigate Dewe Rogerson Life Sciences, will be offering complimentary 1:1 meeting space to during the JP Morgan Healthcare Week for in invited on-site innovators and notable Asian healthcare investors from […]

Read More…

TPP Healthcare Launches New Website to Provide Stronger Insight to the World of Cross-Border Trade

Company News, Industry Updates, Innovation, Investor Relations

TPP Healthcare, a strategic advisory firm specializing in cross-border transactions between Western and Chinese healthcare companies, announces its launch of www.tpphealthcare.com – a direct market access strategy site. On the site, current and prospective clients will find useful information about the global healthcare industry, TPP’s services and recent company production numbers. Additionally, viewers will gain valuable insight […]

Read More…

TPP Healthcare Successfully Implements Legacy Healthcare into China

Chinese Healthcare, Company News, Industry Updates

TPP Healthcare Successfully Implements Legacy Healthcare into China TPP Healthcare, a strategic advisory firm specializing in cross-border transactions between Western and Chinese healthcare companies, announces another successful Chinese expansion – partnering Legacy Healthcare, a Swiss-based R&D firm, with Maxhealth, a Chinese commercial healthcare firm. Legacy Healthcare is a biopharma player developing innovative drugs in oncology […]

Read More…

Industry Headlines I Care About…

Chinese Healthcare, Industry Updates, Innovation, Investor Relations

News Round Up! My Communications Team recently flagged some articles I thought I’d share. Outside of the CFDA publishing a draft Decision for Adjusting the Administrative Regime for Import Drug Registrations, there is a lot of movement in the cross-border healthcare front… The Wall Street Journal: China Emerges as Powerhouse for Biotech Drugs Drugs are classified into two major categories based […]

Read More…

My Time at CPEA

Chinese Healthcare, Company News, Events, Industry Updates, Innovation, Investor Relations

Today I had the honor of speaking at the annual Chinese Pharmaceutical Enterprises Association (CPEA) Meeting. Key talking points were: Why is China relevant to my NA/EU clients: The importance of the Chinese healthcare market and Chinese capital to the outside world. Why Chinese should invest in these overseas markets: I stressed the real opportunity […]

Read More…

In the News…

Chinese Healthcare, Industry Updates, Innovation, Investor Relations

News Round Up!   FierceBiotech: Donald Trump’s First 100 Days, and beyond, for BiopharmaThe article looks at what the next four years could mean for the biopharma industry through Trump’s picks for healthcare top jobs and the power his policies will have over regulatory terms and drug pricing. BioSpectrum Asia: China Will Continue to Rise as a Key Base […]

Read More…

2017 Starts Strong: Success in San Francisco

Chinese Healthcare, Company News, Events, Industry Updates, Innovation

For those of you who joined us last month, a warm thank you is owed. Our TPP Healthcare China Partnering Forum during JPM Healthcare Week was a homerun. The numbers: 300 attendees throughout the week, 500 live-stream registrants in China, 80 panelists, 60+ gallons of coffee, endless one-on-one meetings in our private ballrooms and 8K+ impressions […]

Read More…

The China Partnering Forum at AdvaMed 2016 Proved a Success with More Than 150 Partnering Meetings Held

Chinese Healthcare, Company News, Events, Industry Updates

The China Partnering Forum fostered partnerships among 100 companies and produced profound insights on healthcare cross-border activities from key industry players. Last month, TPP Healthcare closed its second annual China Partnering Forum with 200+ panel attendees and 150+ partnering meetings. Held at the center of city Minneapolis during AdvaMed 2016, the China Partnering Forum drew […]

Read More…

AdvaMed 2016 – Day One

Chinese Healthcare, Company News, Events, Industry Updates

Yesterday’s ‘Opportunities and Obstacles for Medial Technology Innovation Solutions: China & the United States’ panel was a success. Our panel at AdvaMed 2016 examined these countervailing forces in both China and the United States, and had active audience participation in an open discussion on the environment for innovation and commercialization in both countries. Excited to see what the rest […]

Read More…

Just announced this week: TPP Healthcare to Host China Partnering Forum at Leading MedTech Conference

Chinese Healthcare, Company News, Events, Industry Updates

Our forum will provide AdvaMed 2016 attendees real-time insight on healthcare cross-border activities and direct one-on-one meetings with Chinese healthcare and investment institutions.  TPP Healthcare, our global advisory firm specializing in deal flows targeting China’s healthcare sector, announced its China Partnering Forum at AdvaMed 2016: The MedTech Conference for the second consecutive year. The forum will take […]

Read More…